Medication info
Jadimet 12.5/1000 mg (Empagliflozin, Metformin Hydrochloride)

Jadimet 12.5/1000 mg (Empagliflozin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
Biconvex oval film-coated tablets that are dark brownish purple
Packaging
60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 60 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202302631 · Approved 2023.09.04 · Insurance code 644915250

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Difficulties in blood sugar control in type 2 diabetes
  • poor blood sugar control
  • cardiovascular diseases
View approved original text

This medication helps improve blood sugar control in adult patients with type 2 diabetes taking empagliflozin and metformin together. It can be used in conjunction with dietary and exercise therapies for effective blood sugar management. It should be used cautiously in adults with type 2 diabetes where blood sugar is not adequately controlled, particularly if there is existing cardiovascular disease; relevant side effects and clinical trial results should be referred to for expert information. This medication improves blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication is used for the treatment of diabetes, with two main ingredients acting together to control blood sugar. Care must be taken when taking this medication, as a rare complication known as severe lactic acidosis may occur. Lactic acidosis can lead to hazardous levels of lactic acid in the body and poses a life-threatening risk. Additionally, when taken with other diabetes medications like insulin or sulfonylureas, there is a risk of hypoglycemia, so blood sugar levels should be closely monitored. This medication should not be used in patients with moderate to severe kidney dysfunction, nor in cases of rapidly deteriorating kidney function, severe infections, heart failure, or acute myocardial infarction. If undergoing examinations using iodinated contrast agents, it is imperative to pause taking this medication for a period before and after testing, and it can only be resumed after confirming normal kidney function. It is safest not to use this medication in pregnant or potentially pregnant women or nursing mothers. Regular monitoring of kidney function and blood creatinine levels is recommended while taking this medication to ensure there are no issues. Patients at risk of volume depletion or elderly patients should be cautious of dehydration or hypotension, and the medication can be temporarily discontinued as needed. This medication may increase urine output and raise the risk of urinary tract infections or genital infections, so consult a healthcare professional immediately if symptoms occur. Vitamin B12 levels may decrease over long-term use, so monitoring vitamin B12 levels in the blood is suggested for patients taking this medication for extended periods. When taken with insulin or sulfonylureas, consideration should be given to adjusting the dose of those medications to reduce the risk of hypoglycemia. In cases of overdose, serious side effects such as lactic acidosis may occur, so it is important to take the medication as prescribed by a physician. Safety and efficacy in children have not been established, and it is not recommended for those under 18 years of age. Patients should avoid alcohol consumption while taking this medication, and in special situations such as acute illness or surgery, they should consult with healthcare professionals to potentially pause taking the medication temporarily. Additionally, studies on the effects of this medication on driving or operating machinery are insufficient, so caution is advised. Regular check-ups and consultations with healthcare professionals are important for safe use of this medication, and it is necessary to report any abnormal symptoms immediately.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
Show 202 more
  • abnormal liver function test
  • hepatitis
  • altered taste
  • itching
  • rash
  • hives
  • erythema
  • angioedema
  • urinary difficulty
  • interstitial nephritis
  • thirst
  • increased serum lipid
  • increased serum creatinine
  • decreased glomerular filtration rate
  • decreased and deficiency of vitamin B12
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
  • perineal necrosis
  • vulvar moniliasis
  • vulvovaginitis
  • balanitis
  • headache
  • dizziness
  • weakness
  • discomfort in the chest
  • chest pain
  • vascular stent stenosis
  • vascular stent thrombosis
  • fever
  • chills
  • unusual sensation
  • edema
  • pain
  • increased serum creatinine
  • increased hematocrit
  • increased serum creatinine
  • increased serum creatinine
  • increased serum creatinine
  • weight loss
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • intestinal bleeding
  • soft tissue infection
  • pneumonia
  • damage
  • ankle fracture
  • lateral epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • myocardial infarction
  • pancreatic carcinoma
  • constipation
  • gastritis
  • dry mouth
  • gastrointestinal disorders
  • oral discomfort
  • salivary gland pain
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • appendiceal abscess
  • appendicitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • meningitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tinea corporis
  • dental abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • nasopharyngitis
  • position-related dizziness
  • sensory loss
  • paresthesia
  • amnesia
  • carotid artery stenosis
  • diabetic neuropathy
  • facial paralysis
  • intracranial aneurysm
  • memory impairment
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • sensory disturbance
  • drowsiness
  • CNS-origin vertigo
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • facial swelling
  • chills
  • abnormal lipid metabolism
  • hyperglycemia
  • hyponatremia
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosis
  • eye discomfort
  • conjunctival hyperemia
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • retinal detachment with holes
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • moist cough
  • allergic rhinitis
  • phlegm retention
  • cough
  • epistaxis
  • allergic rhinitis
  • skin laceration
  • bruise
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open eye injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular disorder
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorder
  • anxiety
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • position-related vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • vulvar pruritus
  • genital pruritus
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture. It is important to keep the storage temperature between 1 and 30 degrees Celsius to maintain the efficacy of the medication.

Appearance and packaging

Appearance

Biconvex oval film-coated tablets that are dark brownish purple

Package unit

60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 60 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.